WHO Director-General speaks at the 60th Commission on Narcotic Drugs

WHO Director-General speaks at the Commission on Narcotic Drugs

13 March 2017 – WHO Director-General Dr Margaret Chan urged international policymakers and partners at the 60th session of the Commission on Narcotic Drugs in Vienna, Austria, to ensure that policies be based on the medical and scientific evidence, and not on emotions or ideology. She said "We must never forget that the ultimate objective of drug control policies is to save lives."

@CND_tweets (UNODC)
Health worker in a laboratory, Kyrgyzstan, 2016

Hepatitis B and C testing guidelines released

16 February 2017 - Testing and diagnosis of hepatitis B and C infection is the gateway for access to both prevention and treatment services, and is a crucial component of an effective response. WHO has made available the full version of its first guidelines on hepatitis B and C testing today. The guidelines outline the public health approach to strengthening and expanding current testing practices, and are intended for use across age groups and populations.

WHO/Jaken Chotoev
Call for submissions to #HepSummit2017

Call for submissions to #HepSummit2017

6 February 2017 –The World Hepatitis Summit 2017 will be held by the World Health Organization, the World Hepatitis Alliance and the Government of Brazil on 1–3 November in São Paulo, Brazil. The biennial event aims to advance the viral hepatitis agenda and garner global and national actions to achieve the goal to eliminate viral hepatitis by 2030. All individuals and organizations are invited to submit original contributions on how to achieve the elimination goal, by 1 May 2017. Authors of successful submissions will be invited to present their work at the Summit.

Health worker at a mobile testing clinic

First WHO prequalified hepatitis C rapid test opens the door to expanded treatment

6 December 2016 - WHO has just prequalified its first hepatitis C virus (HCV) rapid diagnostic test, a tool that will aid diagnosis of HCV in low- and middle-income countries and improve access to treatment. “The majority of people with chronic hepatitis C don’t know they have the infection and miss the opportunity to be cured,” said Dr Gottfried Hirnschall, WHO Director for the Department of HIV and Global Hepatitis Programme. “Making the first WHO prequalified test available in countries can greatly contribute to achieving the goal of eliminating hepatitis.”

Group of people clapping hands

Over 1 million treated with highly effective hepatitis C medicines

27 October 2016 – The World Health Organization launches its first-ever report on access to hepatitis C treatment today. The report shows encouraging progress in developing countries where more than 1 million people have been treated with a revolutionary new cure for hepatitis C. Despite this progress, most people in need still lack treatment and more global effort is required to overcome barriers to access. The report shows several countries are championing the scale-up of hepatitis C treatment with political will, partnerships, negotiations to reduce prices and the introduction of generic medicines.


fact buffet

Global burden

400 millionViral hepatitis affects 400 million people globally. Every year 6–10 million people are newly infected.

For more: fact sheet on hepatitis B

Silent killer

1.4 millionGlobally, about 1.4 million people die each year from hepatitis.

For more: global strategy on viral hepatitis

Effective treatment

90%Over 90% of people with hepatitis C can be completely cured within 3–6 months.

For more: fact sheet on hepatitis C

World Hepatitis Day

World Hepatitis Summit

World Hepatitis Summit 2017

Date: 1-3 November 2017 Place: São Paulo, Brazil

Global strategy